These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25329387)

  • 1. Reputation and competition in a hidden action model.
    Fedele A; Tedeschi P
    PLoS One; 2014; 9(10):e110233. PubMed ID: 25329387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumer Behavior Under Conflicting Information Provided by Interested Parties: Implications for Equilibrium in the Market for Credence Goods.
    Russo C; Tufi E
    Recent Pat Food Nutr Agric; 2016; 8(1):4-8. PubMed ID: 26825754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A linear city model with asymmetric consumer distribution.
    Azar OH
    PLoS One; 2015; 10(6):e0129068. PubMed ID: 26034984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paying for express checkout: competition and price discrimination in multi-server queuing systems.
    Deck C; Kimbrough EO; Mongrain S
    PLoS One; 2014; 9(3):e92070. PubMed ID: 24667809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching costs in competitive health insurance markets: The role of insurers' pricing strategies.
    Lamiraud K; Stadelmann P
    Health Econ; 2020 Sep; 29(9):992-1012. PubMed ID: 32542729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition and the Reference Pricing Scheme for pharmaceuticals.
    Ghislandi S
    J Health Econ; 2011 Dec; 30(6):1137-49. PubMed ID: 21937137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive pricing within pharmaceutical classes: evidence on "follow-on" drugs in Germany 1993-2008.
    Mueller MT; Frenzel A
    Eur J Health Econ; 2015 Jan; 16(1):73-82. PubMed ID: 24370790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An empirical analysis of the multimarket contact theory in pharmaceutical markets.
    Coronado J; Jiménez-Martín S; Marín PL
    Eur J Health Econ; 2014 Jul; 15(6):623-43. PubMed ID: 23818281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition in the pharmaceutical industry: how do quality differences shape advertising strategies?
    de Frutos MA; Ornaghi C; Siotis G
    J Health Econ; 2013 Jan; 32(1):268-85. PubMed ID: 23237791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition and quality in a physiotherapy market with fixed prices.
    Pekola P; Linnosmaa I; Mikkola H
    Eur J Health Econ; 2017 Jan; 18(1):97-117. PubMed ID: 27037838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Pricing and Return-Freight Insurance: Strategic Analysis of
    Yang Y; Chai R; Sun X; Li Y
    J Syst Sci Complex; 2022; 35(6):2302-2318. PubMed ID: 36590987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyper-competition, collusion, free riding or coopetition: basins of attraction when firms simultaneously compete and cooperate.
    Pathak S; Pokharel MP; Mahadevan S
    Nonlinear Dynamics Psychol Life Sci; 2013 Jan; 17(1):133-57. PubMed ID: 23244753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does capital structure change product-market competitiveness? Evidence from Chinese firms.
    Li L; Wang Z
    PLoS One; 2019; 14(2):e0210618. PubMed ID: 30721237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Price competition in pharmaceuticals - Evidence from 1303 Swedish markets.
    Granlund D; Bergman MA
    J Health Econ; 2018 Sep; 61():1-12. PubMed ID: 30007260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The entry of Colombian-sourced heroin into the US market: the relationship between competition, price, and purity.
    Rosenblum D; Unick GJ; Ciccarone D
    Int J Drug Policy; 2014 Jan; 25(1):88-95. PubMed ID: 24211155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coevolution of trustful buyers and cooperative sellers in the trust game.
    Masuda N; Nakamura M
    PLoS One; 2012; 7(9):e44169. PubMed ID: 22970176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Market power in the United States red meatpacking industry.
    Koontz SR
    Vet Clin North Am Food Anim Pract; 2003 Jul; 19(2):519-44. PubMed ID: 12951745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurer Market Power Lowers Prices In Numerous Concentrated Provider Markets.
    Scheffler RM; Arnold DR
    Health Aff (Millwood); 2017 Sep; 36(9):1539-1546. PubMed ID: 28874479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of generic competition on prescription to over-the-counter switching.
    Hollenbeak CS
    Pharmacoeconomics; 1999 Dec; 16(6):661-8. PubMed ID: 10724793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.